Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Prime Medicine, Inc.

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsJun-30-23Mar-31-23Dec-31-22Sep-30-22Jun-30-22
   10-Q10-Q10-K10-Q10-Q
Revenues  45.326.326.326.326.3
            Revenue growth  72.0%    
Cost of goods sold  45.326.326.326.326.3
Gross profit  0.00.00.00.00.0
            Gross margin  0.0%0.0%0.0%0.0%0.0%
Selling, general and administrative   [+]36.032.829.827.423.8
Research and development   85.067.891.6 
Other operating expenses  34.6   18.9
EBITDA   [+]-152.0-133.7-114.3-136.4-115.6
            EBITDA margin  -335.8%-508.3%-434.6%-518.3%-439.4%
Depreciation and amortization  3.73.02.21.61.1
EBIT   [+]-155.6-136.7-116.5-137.9-116.7
            EBIT margin  -343.9%-519.6%-443.0%-524.4%-443.7%
Other income (expense), net  4.9-1.1-6.3-5.4-18.8
Pre-tax income  -150.8-137.7-122.8-143.3-135.6
Income taxes  -0.20.3-0.11.5-1.1
            Tax rate  0.1%-0.2%0.1%  
Net income  -158.1-151.3-142.0-170.7-157.8
            Net margin  -349.3%-575.4%-539.9%-648.9%-599.7%
   
Basic EPS   [+]($2.68)($3.66)($5.95)($9.17)($9.39)
Diluted EPS   [+]($2.68)($3.66)($5.95)($9.17)($9.39)
   
Shares outstanding (basic)   [+]58.941.423.818.616.8
Shares outstanding (diluted)   [+]58.941.423.818.616.8
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy